Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    VolitionRx

    MCap

    USD76m

    Last close

    USD0.81

    ▲ 0.14 (20.90%)

    Canyon Resources

    MCap

    AUD262m

    Last close

    AUD0.19

    ▲ 0.02 (12.12%)

    Immix Biopharma

    MCap

    USD51m

    Last close

    USD1.82

    ▲ 0.12 (7.06%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Telix Pharmaceuticals (AU: TLX)

Last close As at 21/11/2024

6.94

▲ −0.20 (−2.80%)

Market capitalisation

1,979m

Edison Investment Research is terminating coverage on Telix Pharmaceuticals. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Latest Insights

View More

Healthcare | Update

Telix Pharmaceuticals — 2021 is a major year commercially and clinically

Healthcare | edison tv

Telix Pharmaceuticals – Edison Open House interview

Healthcare | Update

Telix Pharmaceuticals — A new theranostic with a clinical readout in days

Healthcare | Update

Telix Pharmaceuticals — Telix signs a big China deal
Visit Website

Sector

Healthcare

Share Price Performance

Financials

Edison Investment Research is terminating coverage on Telix Pharmaceuticals. Please note you should no longer rely on any previous research or estimates for these companies. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.